Resorbable, amino acid-based poly(ester urea)s crosslinked with osteogenic growth peptide with enhanced mechanical properties and bioactivity

Acta Biomaterialia

Volumn 9, Issue 2, 2013, Pages 5132-5142

  Stakleff, Kimberly Sloan ^a   Lin, Fei ^b   Smith Callahan, Laura A ^b   Wade, Mary Beth ^a   Esterle, Andrew ^a   Miller, James ^b   Graham, Matthew ^c   Becker, Matthew L ^b,d  

^a AKRON GENERAL MEDICAL CENTER   (United States)

^b The University of Akron   (United States)

^c Akron Polymer Systems   (United States)

^d Austen BioInnovation Institute   (United States)

Author keywords

Biomaterials; Degradable; Osteogenic growth peptide; Poly(ester urea); Tissue engineering

Indexed keywords

AMINO ACIDS; BIOMATERIALS; CROSSLINKING; ESTERS; METABOLISM; PEPTIDES; SCAFFOLDS (BIOLOGY);

AMINO-ACIDS; CROSSLINKER; DEGRADABLE; GROWTH FACTOR; IN-VIVO; OSTEOGENIC GROWTH PEPTIDES; POLIES (ESTER); POLY(ESTER UREA); RESORBABLE; TISSUES ENGINEERINGS;

UREA;

BIOMATERIAL; GROWTH FACTOR; OSTEOGENIC GROWTH PEPTIDE; POLY(ESTER UREA); POLYESTER; POLYMER; RECOMBINANT GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; DRUG ACTIVITY; FIBROBLAST; GIANT CELL; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; POLYMERIZATION; PREPUCE; PRIORITY JOURNAL; RAT; TENSILE STRENGTH; THICKNESS; TISSUE ENGINEERING; YOUNG MODULUS;

RATTUS;

EID: 84872091480     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.08.035     Document Type: Article

References (65)

1. J.C. Middleton, and A.J. Tipton Synthetic biodegradable polymers as orthopedic devices Biomaterials 21 2000 2335
2. K.A. Athanasiou, C.M. Agrawal, F.A. Barber, and S.S. Burkhart Orthopaedic applications for PLA-PGA biodegradable polymers Arthrosc: J Arthrosc Relat Surg 14 1998 726
3. K.A. Athanasiou, G.G. Niederauer, and C.M. Agrawal Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymers Biomaterials 17 1996 93
4. K. Anselme, B. Flautre, P. Hardouin, M. Chanavaz, C. Ustariz, and M. Vert Fate of bioresorbable poly(lactic acid) microbeads implanted in artificial bone defects for cortical bone augmentation in dog mandible Biomaterials 14 1993 44
5. S.S. Liao, F.Z. Cui, W. Zhang, and Q.L. Feng Hierarchically biomimetic bone scaffold materials: nano-HA/collagen/PLA composite J Biomed Mater Res B Appl Biomater 69B 2004 158
6. S. Wang, L. Lu, and M.J. Yaszemski Bone-tissue-engineering material poly(propylene fumarate): correlation between molecular weight, chain dimensions, and physical properties Biomacromolecules 7 2006 1976
7. J.P. Fisher, J.W.M. Vehof, D. Dean, J.P.C.M. van der Waerden, T.A. Holland, and A.G. Mikos Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model J Biomed Mater Res 59 2002 547
8. A.S. Mistry, S.H. Cheng, T. Yeh, E. Christenson, J.A. Jansen, and A.G. Mikos Fabrication and in vitro degradation of porous fumarate-based polymer/alumoxane nanocomposite scaffolds for bone tissue engineering J Biomed Mater Res A 89A 2009 68
9. J.M. Williams, A. Adewunmi, R.M. Schek, C.L. Flanagan, P.H. Krebsbach, and S.E. Feinberg Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering Biomaterials 26 2005 4817
10. C. Choong, J.T. Triffitt, and Z.F. Cui Polycaprolactone scaffolds for bone tissue engineering: effects of a calcium phosphate coating layer on osteogenic cells Food Bioprod Process 82 2004 117
11. P.X. Ma, and J.W. Choi Biodegradable polymer scaffolds with well-defined interconnected spherical pore network Tissue Eng 7 2001 23
12. H. Tsuji, and Y. Ikada Properties and morphologies of poly(l-lactide).1. Annealing condition effects on properties and morphologies of poly(l-lactide) Polymer 36 1995 2709
13. G.B. Wei, and P.X. Ma Structure and properties of nano-hydroxyapatite/ polymer composite scaffolds for bone tissue engineering Biomaterials 25 2004 4749
14. D.T. Reilly, A.H. Burstein, and V.H. Frankel The elastic modulus for bone J Biomech 7 1974 271
15. J.Y. Rho, R.B. Ashman, and C.H. Turner Young's modulus of trabecular and cortical bone material: ultrasonic and microtensile measurements J Biomech 26 1993 111
16. M. Navarro, A. Michiardi, O. Castaño, and J.A. Planell Biomaterials in orthopaedics J R Soc Interface 5 2008 1137
17. A.U. Daniels, M.K.O. Chang, K.P. Andriano, and J. Heller Mechanical properties of biodegradable polymers and composites proposed for internal fixation of bone J Appl Biomater 1 1990 57
18. G.C. Babis, and P.N. Soucacos Bone scaffolds: the role of mechanical stability and instrumentation Injury 36 2005 S38
19. H. Sun, F. Meng, A.A. Dias, M. Hendriks, J. Feijen, and Z. Zhong α-Amino acid containing degradable polymers as functional biomaterials: rational design, synthetic pathway, and biomedical applications Biomacromolecules 12 2011 1937
20. S.L. Bourke, and J. Kohn Polymers derived from the amino acid l-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol) Adv Drug Deliv Rev 55 2003 447
21. E. Katchalski-Katzir Synthesis, structure and function of poly-α-amino acids-the simplest of protein models Cell Mol Life Sci 53 1997 780
22. A.E. Rydholma, C.N. Bowman, and K.S. Anseth Degradable thiol-Acrylate photopolymers: polymerization and degradation behavior of an in situ forming biomaterial Biomaterials 26 2005 4495
23. M.P. Lutolf, and J.A. Hubbell Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering Nat Biotech 23 2005 47
24. L.S.N.C.T. Laurencin Polymers as biomaterials for tissue engineering and controlled drug delivery Adv Biochem Engin/Biotechnol 102 2006 47
25. L.S. Nair, and C.T. Laurencin Biodegradable polymers as biomaterials Prog Polym Sci 32 2007 762
26. J.M. Holzwarth, and P.X. Ma Biomimetic nanofibrous scaffolds for bone tissue engineering Biomaterials 32 2011 9622
27. I.L. Kim, R.L. Mauck, and J.A. Burdick Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid Biomaterials 32 2011 8771
28. C. Zhong, and C.C. Chu Biomimetic mineralization of acid polysaccharide-based hydrogels: towards porous 3-dimensional bone-like biocomposites J Mater Chem 22 2012 6080
29. H. Shin, S. Jo, and A.G. Mikos Biomimetic materials for tissue engineering Biomaterials 24 2003 4353
30. B.T. Liberelle, C. Boucher, J. Chen, M. Jolicoeur, Y. Durocher, and G. De Crescenzo Impact of epidermal growth factor tethering strategy on cellular response Bioconjugate Chem 21 2010 2257
31. Y. Ito, M. Inoue, S.Q. Liu, and Y. Imanishi Cell growth on immobilized cell growth factor. 6. Enhancement of fibroblast cell growth by immobilized insulin and/or fibronectin J Biomed Mater Res 27 1993 901
32. I. Bab, D. Gazit, M. Chorev, A. Muhlrad, A. Shteyer, and Z. Greenberg Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity EMBO J 11 1992 1867
33. Z. Greenberg, M. Chorev, A. Muhlrad, A. Shteyer, M. Namdarattar, and N. Casap Structural and functional-characterization of osteogenic growth peptide from human serum - identity with rat and mouse homologs J Clin Endocrinol Metab 80 1995 2330
34. Z.X. Chen, M. Chang, Y.L. Peng, L. Zhao, Y.R. Zhan, and L.J. Wang Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes Regul Pept 142 2007 16
35. N. Gabarin, H. Gavish, A. Muhlrad, Y.C. Chen, M. Namdar-Attar, and R.A. Nissenson Mitogenic G(i) protein-MAP kinase signaling cascade in MC3T3-E1 osteogenic cells: activation by C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)] and attenuation of activation by cAMP J Cell Biochem 81 2001 594
36. L. Mattii, B. Battolla, S. Moscato, R. Fazzi, S. Galimberti, and N. Bernardini The small peptide OGP(10-14) acts through Src kinases and RhoA pathways in Mo-7e cells: morphologic and immunologic evaluation Med Sci Monit 14 2008 BR103
37. L. Mattii, R. Fazzi, S. Moscato, C. Segnani, S. Pacini, and S. Galimberti Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA J Cell Biochem 93 2004 1231
38. Y. Gabet, R. Muller, E. Regev, J. Sela, A. Shteyer, and K. Salisbury Osteogenic growth peptide modulates fracture callus structural and mechanical properties Bone 35 2004 65
39. N.M. Moore, N.J. Lin, N.D. Gallant, and M.L. Becker The use of immobilized osteogenic growth peptide on gradient substrates synthesized via click chemistry to enhance MC3T3-E1 osteoblast proliferation Biomaterials 31 2010 1604
40. M. Shuqiang, W. Kunzheng, D. Xiaoqiang, W. Wei, Z. Mingyu, and W. Daocheng Osteogenic growth peptide incorporated into PLGA scaffolds accelerates healing of segmental long bone defects in rabbits J Plast Reconstr Aesthet Surg 61 2008 1558
41. L.L. Hench, and J.M. Polak Third-generation biomedical materials Science 295 2002 1014
42. X. Pang, and C.-C. Chu Synthesis, characterization and biodegradation of functionalized amino acid-based poly(ester amide)s Biomaterials 31 2010 3745
43. R. Katsarava, V. Beridze, N. Arabuli, D. Kharadze, C.C. Chu, and C.Y. Won Amino acid-based bioanalogous polymers. Synthesis, and study of regular poly(ester amide)s based on bis(alpha-Amino acid) alpha, omega-Alkylene diesters, and aliphatic dicarboxylic acids J Polym Sci Part A: Polym Chem 37 1998 391
44. T. Kasuga, Y. Ota, M. Nogami, and Y. Abe Preparation and mechanical properties of polylactic acid composites containing hydroxyapaptie fibers Biomaterials 22 2001 19
45. M. Avella, M.E. Errico, P. Laurienzo, E. Martuscelli, M. Ramio, and R. Rimedio Preparation and characterisation of compatibilised polycaprolactone/ starch composites Polymer 41 2000 3875
46. J.M. Anderson, A. Rodriguez, and D. Chang Foreign body reaction to biomaterials Semin Immunol 20 2008 86
47. G.M. Crane, S.L. Ishaug, and A.G. Mikos Bone tissue engineering Nat Med 1 1995 1322
48. J.A. Hubbell Biomaterials in tissue engineering Biotechnology 13 1995 565
49. J. Kohn, and R.L. Langer Bioresorbable and bioerodible materials B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemon, An Introduction to Materials in Medicine 1997 Academic Press San Diego 65
50. R. Langer, and D.A. Tirrell Designing materials for biology and medicine Nature 428 2004 487
51. M.J. Yaszemski, R.G. Payne, W.C. Hayes, R. Langer, and A.G. Mikos Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone Biomaterials 17 1996 175
52. K.A. Aamer, K.L. Genson, J. Kohn, and M.L. Becker Impact of polymer-bound iodine on fibronectin adsorption and osteoblast cell morphology in radiopaque medical polymers: tyrosine-derived polycarbonate blends as a model system Biomacromolecules 10 2009 2418
53. L. Bailey, M.L. Becker, J.S. Stephens, C.M. Mahoney, N.R. Washburn, and A. Rege Cellular response to phase-separated blends of tyrosine derived polycarbontates J Biomed Mater Res 76A 2006 491
54. S.L. Bourke, and J. Kohn Polymers derived from the amino acid l-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol) Adv Drug Deliv Rev 55 2003 447
55. S.I. Ertel, and J. Kohn Evaluation of tyrosine-derived polycarbonates as degradable biomaterials J Biomed Mater Res 28 1994 919
56. J. Kohn New approaches to biomaterials design Nat Mater 3 2004 745
57. D.S. Muggli, A.K. Burkoth, S.A. Keyser, H.R. Lee, and K.S. Anseth Reaction behavior of biodegradable, photo-cross-linkable polyanhydrides Macromolecules 31 1998 4120
58. V. Tangpasuthadol, S.M. Pendharkar, and J. Kohn Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I: study of model compounds Biomaterials 21 2000 2371
59. V. Tangpasuthadol, S.M. Pendharkar, R.C. Peterson, and J. Kohn Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part II: 3-yr study of polymeric devices Biomaterials 21 2000 2379
60. Z.X. Chen, M. Chang, Y.L. Peng, L. Zhao, Y.R. Zhan, and L.J. Wang Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes Regul Pept 142 2007 16
61. N. Gabarin, H. Gavish, A. Muhlrad, Y.C. Chen, M. Namdar-Attar, and R.A. Nissenson Mitogenic G(i) protein-MAP kinase signaling cascade in MC3T3-E1 osteogenic cells: activation by C-terminal pentapeptide of osteogenic growth peptide [OGP(10-14)] and attenuation of activation by cAMP J Cell Biochem 81 2001 594
62. Z. Greenberg, M. Chorev, A. Muhlrad, A. Shteyer, M. Namdarattar, and N. Casap Structural and functional-characterization of osteogenic growth peptide from human serum - identity with rat and mouse homologs J Clin Endocrinol Metab 80 1995 2330
63. Z. Greenberg, H. Gavish, A. Muhlrad, M. Chorev, A. Shteyer, and M. Attar-Namdar Isolation of osteogenic growth peptide from osteoblastic MC3T3 E1 cell cultures and demonstration of osteogenic growth peptide binding proteins J Cell Biochem 65 1997 359
64. M. Szpalski, and R. Gunzburg Applications of calcium phosphate-based cancellous bone void fillers in trauma surgery Orthopedics 25 2002 601
65. R.S. Raghuvanshi, S. Goyal, O. Singh, and A.K. Panda Stabilization of dichloromethane-induced protein denaturation during microencapsulation Pharm Dev Technol 3 1998 269